Pre-market: 21P1.F Aurora Cannabis (XETRA) €0.36 top loser: 12m fair value €0.42

21P1.F stock is trading in the XETRA pre-market at €0.36, down 2.86% from the previous close and showing elevated volume of 45,274 shares. Aurora Cannabis Inc. (21P1.F) ranks among today’s top losers on the Germany exchange as traders weigh weak sector momentum and stretched inventory metrics. We examine price action, fundamentals and a model-based 12‑month outlook to explain why the stock is under pressure and which levels matter for short-term traders and longer-term investors.

Pre-market price action and trading signals for 21P1.F stock

21P1.F stock opened at €0.37, with a day low of €0.36 and a day high of €0.37; the pre-market move leaves the share price -2.86% versus the previous close of €0.37. Volume is running at 45,274, about 2.35x the average daily volume of 19,230, which signals higher intraday attention.

Fundamental snapshot: Aurora Cannabis (21P1.F) valuation and metrics

Aurora Cannabis Inc. (21P1.F) reports an EPS of -54.44 and a negative P/E, reflecting ongoing losses; market cap on XETRA is €19,639,638.00 and shares outstanding are 54,539,400.00. The company shows a strong current ratio of 3.42 and cash per share of €2.29, while book value per share stands at €11.74, giving a low price-to-book ratio of 0.05, which highlights balance‑sheet strength despite operating losses.

Sector context and risks: Healthcare comparison for 21P1.F stock

The Healthcare sector on our Germany coverage has an average current ratio of 2.74 and average PE around 28.79, while Aurora’s metrics show deeper losses and a longer inventory cycle at 490.04 days of inventory on hand. This inventory and margin profile increases execution risk versus sector peers and helps explain why 21P1.F stock is lagging the wider healthcare group.

Meyka AI rates 21P1.F with a score out of 100 and technical outlook

Meyka AI rates 21P1.F with a score of 62.45 out of 100 (Grade B, suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The technical picture shows price below the 50‑day average (€0.41) and 200‑day average (€0.48), keeping the short-term trend negative and highlighting resistance in the €0.41–€0.48 band.

Price drivers and Meyka AI’s forecast for 21P1.F stock

Meyka AI’s forecast model projects a 12‑month fair value of €0.42, implying an upside of 16.64% from the current €0.3601. Forecasts are model‑based projections and not guarantees. On the downside, a risk target at €0.25 would imply a potential decline of -30.56%, showing asymmetric outcomes tied to execution on inventory reduction and margin recovery.

Trading ideas and risk management for the top loser 21P1.F stock

Short‑term traders may watch €0.35 as immediate support and €0.41 as first resistance; increased volume on dips would signal allocation interest. For longer-term investors, the combination of high book value per share and negative cash flow metrics suggests a wait‑and‑see approach until EBITDA trends improve. These grades are not guaranteed and we are not financial advisors.

Final Thoughts

Key takeaways: 21P1.F stock is a clear pre-market top loser on XETRA at €0.3601, pressured by extended inventory days and persistent negative EPS of -54.44. The balance sheet shows strength—book value per share €11.74 and cash per share €2.29—but operating cash flow and margins remain weak. Meyka AI’s forecast model projects a 12‑month fair value of €0.42, an implied upside of 16.64% versus the current price; this projection is model‑based and not a guarantee. Traders should treat the stock as high volatility: short-term trades need strict stop levels (support €0.35, risk target €0.25) while longer-term holders should look for consistent EBITDA improvement and inventory drawdown before adding exposure. Our analysis combines market flow, sector comparisons and the Meyka AI grade to frame both opportunity and downside risk on Aurora Cannabis (21P1.F) listed on XETRA in Germany, priced in EUR.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.